Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Potestio

Showing results (71-80 of 138) with videos related to

Pageof 14
Sort By:
Clinical, Cosmetic and Investigational Dermatology|September 25, 2023
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life DataFabrizio Martora, Massimiliano Scalvenzi, Teresa Battista, et al.
Life (Basel, Switzerland)|April 28, 2023
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future?Fabrizio Martora, Gabriella Fabbrocini, Matteo Megna, et al.
The Journal of Dermatological Treatment|May 22, 2024
Effectiveness and safety of risankizumab in VEry severe plaque psoriasis: a real-life retrospective study (VESPA-Study)Diego Orsini, Chiara Assorgi, Claudio Bonifati, et al.
Drugs in Context|November 28, 2025
Biologics and small molecules for psoriasis: current and future progressLuca Potestio, Nello Tommasino, Michela D'Agostino, et al.
Viruses|January 8, 2025
Pemphigus and Bullous Pemphigoid Following COVID-19 Vaccination: A Systematic ReviewFabrizio Martora, Teresa Battista, Luca Potestio, et al.
Clinical, Cosmetic and Investigational Dermatology|July 5, 2023
Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?Matteo Megna, Elisa Camela, Angelo Ruggiero, et al.
Expert Opinion on Drug Safety|August 12, 2024
Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasisTeresa Battista, Vincenzo Picone, Matteo Noto, et al.
Advances in Therapy|May 6, 2024
Management of Psoriasis Patients with Serious Infectious DiseasesMatteo Megna, Giuseppe Lauletta, Nello Tommasino, et al.
Clinical, Cosmetic and Investigational Dermatology|November 6, 2023
JAK Inhibitors in Psoriatic DiseaseMatteo Megna, Luca Potestio, Angelo Ruggiero, et al.
Psoriasis (Auckland, N.Z.)|June 4, 2024
Risk Factors for Psoriasis Flares: A Narrative ReviewLuca Potestio, Giuseppe Lauletta, Nello Tommasino, et al.
Pageof 14

Showing results (71-80 of 138) with videos related to

Sort By:
Pageof 14
Clinical, Cosmetic and Investigational Dermatology|September 25, 2023
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life DataFabrizio Martora, Massimiliano Scalvenzi, Teresa Battista, et al.
Life (Basel, Switzerland)|April 28, 2023
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future?Fabrizio Martora, Gabriella Fabbrocini, Matteo Megna, et al.
The Journal of Dermatological Treatment|May 22, 2024
Effectiveness and safety of risankizumab in VEry severe plaque psoriasis: a real-life retrospective study (VESPA-Study)Diego Orsini, Chiara Assorgi, Claudio Bonifati, et al.
Drugs in Context|November 28, 2025
Biologics and small molecules for psoriasis: current and future progressLuca Potestio, Nello Tommasino, Michela D'Agostino, et al.
Viruses|January 8, 2025
Pemphigus and Bullous Pemphigoid Following COVID-19 Vaccination: A Systematic ReviewFabrizio Martora, Teresa Battista, Luca Potestio, et al.
Clinical, Cosmetic and Investigational Dermatology|July 5, 2023
Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?Matteo Megna, Elisa Camela, Angelo Ruggiero, et al.
Expert Opinion on Drug Safety|August 12, 2024
Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasisTeresa Battista, Vincenzo Picone, Matteo Noto, et al.
Advances in Therapy|May 6, 2024
Management of Psoriasis Patients with Serious Infectious DiseasesMatteo Megna, Giuseppe Lauletta, Nello Tommasino, et al.
Clinical, Cosmetic and Investigational Dermatology|November 6, 2023
JAK Inhibitors in Psoriatic DiseaseMatteo Megna, Luca Potestio, Angelo Ruggiero, et al.
Psoriasis (Auckland, N.Z.)|June 4, 2024
Risk Factors for Psoriasis Flares: A Narrative ReviewLuca Potestio, Giuseppe Lauletta, Nello Tommasino, et al.
Pageof 14